AngioDynamics To Present At The 32nd Annual Canaccord Growth Conference

ALBANY, N.Y., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Angiodynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 32 nd Annual Canaccord Growth Conference at the Intercontinental Hotel in Boston. AngioDynamics' presentation will be at 3 p.m. Eastern Time, Wednesday, August 15, 2012. Joseph M. DeVivo, President and Chief Executive Officer of AngioDynamics, will review the Company's business strategy and recent corporate developments.

A live webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's Web site under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm . The replay will be available for 90 days after the event.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.angiodynamics.com .
CONTACT: Company Contact:         AngioDynamics, Inc.         D. Joseph Gersuk, CFO         (800) 772-6446 x1608         jgersuk@AngioDynamics.com                  Investor Relations Contacts:         EVC Group, Inc.         Jamar Ismail/Robert Jones         (415) 568-9348; (646) 201-5447         jismail@evcgroup.com;         bjones@evcgroup.com                  Media Contact:         EVC Group, Inc.         Chris Gale         (646) 201-5431         cgale@evcgroup.com

If you liked this article you might like

Endo international, AngioDynamics Lead Biotech Movers

Endo international, AngioDynamics Lead Biotech Movers

As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?

As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?

5 Stocks Everyone Hates -- but You Should Love

5 Stocks Everyone Hates -- but You Should Love

AngioDynamics (ANGO) Strong On High Relative Volume Today

AngioDynamics (ANGO) Strong On High Relative Volume Today

5 Hated Earnings Stocks You Should Love

5 Hated Earnings Stocks You Should Love